De-risking CNS treatment development 25th of May – 6pm CEST

Session one: epilepsy treatment

We are very honored to invite top experts Prof. Eugen Trinka, Dr Neuray, Dr Komorowski, Dr Haubenberger

Final agenda

Optimal EEG use in treatment development by Prof. Eugen Trinka

Current evidence for EEG derived features as potential biomarkers by Dr Caroline Neuray

Real-world evidence sharing by Rob Komorowski (Biogen) and Dietrich Haubenberger (Neurocrine)

Bridging the gap by Epilog –  Jurgen Van Broeck

Subscribe // natasja@epilog.care